铝碳酸镁联合四联疗法治疗幽门螺杆菌感染并十二指肠溃疡的临床效果

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (29 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical effect of Hydrotalcite combined with quadruple therapy in the treatment of helicobacter pylori(Hp)infection and duodenal ulcer(DU).Methods A total of 108 DU patients with HP infection who were visited in the outpatient department of Qianjiang Central Hospital Affiliated to Changjiang University from May 2017 to December 2019 were selected.According to the random digital table method,they were divided into control group(n=54)and study group(n=54).The control group was given a quadruple regimen of Colloidal Bismuth Tartrate,Pantoprazole,Clarithromycin and Amoxicillin.The study group was combined with Hydrotalcite on this regimen.The clinical efficacy and Hp eradication rate of the two groups of patients after treatment were compared,and the changes in serum inflammatory factor levels before and after treatment were compared.Results The total effective rate of treatment and Hp eradication rate in the study group were higher than those in the control group,and the differences were statistically significant(P<0.05).There was no significant difference in the levels of inflammatory factors between the two groups before treatment(P>0.05).After treatment,the levels of serum interleukin-6(IL-6)and tumor necrosis factor alpha (TNF-α)in the study group were lower than those in the control group,the differences were statistically significant(P<0.05).Conclusion Hydrotalcite combined with quadruple therapy can improve the clinical symptoms of DU patients with Hp infection,increase the Hp eradication rate,reduce the level of inflammatory mediators,Improve the degree of inflammation of gastric antrum mucosa,and enhance the efficacy.

Key words： Duodenal ulcer Helicobacter pylori Hydrotalcite Quadruple therapy Inflammatory factors

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHENG Lin
	ZHANG Xian-jun

Cite this article:

CHENG Lin,ZHANG Xian-jun. Clinical effect of Hydrotalcite combined with quadruple therapy in the treatment of helicobacter pylori infection and duodenal ulcer[J]. 中国当代医药, 2021, 28(32): 52-54.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I32/52

[7]	李鑫.铝碳酸镁联合兰索拉唑与单用兰索拉唑治疗幽门螺杆菌相关性胃溃疡的疗效对比[J].现代消化及介入诊疗，2018，23（2）：178-180.
[10]	黄玉洁，刘宏伟，杨剑英，等.心理干预辅助含阿莫西林，呋喃唑酮的四联疗法治疗胃溃疡的效果分析[J].河北医药，2020，42（6）：861-864.
[11]	陆冰云，陈烨.雷贝拉唑四联根除幽门螺杆菌感染对肠道微生态影响[J].临床军医杂志，2018，46（6）：639-641.
[12]	史淑利，杨雁慧，许彤丽，等.铝碳酸镁联合质子泵抑制剂治疗胃溃疡效果分析[J].临床军医杂志，2018，46（10）：1255-1256.
[13]	樊文静，张振宇，杨景玉，等.含铋剂四联疗法治疗幽门螺旋杆菌阳性胃溃疡的临床效果[J].广西医学，2019，41（18）：2306-2308.
[14]	陈兆夷，黄志刚，邓衍部，等.含铋剂四联疗法治疗慢性胃溃疡伴幽门螺杆菌感染患者的临床疗效研究[J].中华生物医学工程杂志，2019，25（6）：763-767.
[15]	钟雄平.含铋剂四联疗法根除幽门螺杆菌感染的临床疗效分析[J].山西医药杂志，2020，49（19）：95-96.
[5]	石鹏，姚洁.黄连素联合四联疗法治疗幽门螺杆菌阳性消化性溃疡的效果及机制探讨[J].中国医药导报，2019，5（22）：77-79.
[8]	樊冬杰，黄玉伟.铝碳酸镁联合四联疗法治疗幽门螺杆菌感染并十二指肠溃疡120例临床观察[J].安徽医药，2020，24（2）：393-397.
[9]	石岩岩，郭燕磊，张婷，等.铝碳酸镁对幽门螺杆菌的抑制作用及其机制[J].中华消化杂志，2018，38（1）：46-50.
[3]	田德安.消化疾病诊疗指南3版[M].北京：科学出版社，2013：234-235.
[4]	中华医学会.临床诊疗指南：消化病及肝病分册[M].北京：人民卫生出版社，2010：362-363.
[6]	刘宏伟，黄玉洁，杨剑英，等.含阿莫西林，呋喃唑酮四联疗法治疗幽门螺杆菌相关性胃溃疡的疗效及安全性分析[J].河北医药，2020，42（8）：50-53.
[16]	李国栋，许亚，朱颖，等.埃索美拉唑治疗幽门螺杆菌阳性十二指肠溃疡的系统评价[J].医药导报，2018，37（1）：83-88.
[1]	张伟，张振榆.丹参合剂联合四联疗法治疗慢性萎缩性胃炎伴幽门螺杆菌感染 48 例[J].西部中医药，2018，31（10）：91-94.
[2]	梅玲华，贺兆平，杨永宏，等.含铋剂四联疗法对幽门螺杆菌阳性小儿消化性溃疡的疗效观察[J].现代消化及介入诊疗，2019，24（4）：73-76.